Multidisciplinary team (MDT) working is essential in children’s cancer care. Dr Ren Manias, Consultant Paediatric Oncologist at Southampton General Hospital and Contact’s medical adviser, explains how effective communication and shared decision making improve survival rates, enhance quality of life, and support children and their families during their cancer journey.
Lisa Radcliffe’s son, George, was diagnosed with rhabdomyosarcoma when he was three years old and sadly died when he was four. Here, she explains how she and her husband, David, quickly found their own approach to communicating with George during his treatment, and how this helped them.
Ellie Philpotts was diagnosed with Hodgkin lymphoma in 2011 aged 15. She explains how she found support from other young people with cancer and how, through awareness raising, writing and advocacy work, she’s hoping to help those who are newly diagnosed.
Sarah Davis' daughter Emma was diagnosed with acute lymphoblastic leukaemia (ALL) as a 12-year-old. She writes about the support the family received and the progress Emma has made since finishing treatment
Nicky Webb, is a clinical nurse specialist for the long-term follow-up of survivors of childhood cancer at the East Midlands Children and Young Person's Integrated Cancer Service. She is also a CCLG member and plays an active role in CCLG's specialist Late Effects Group.
First formed to establish clinical trials in childhood cancer, research has always been an integral part of CCLG’s work. Ellie Ellicott, CCLG Research Communications Executive, tells us more about its research journey and how the experiences of those that matter the most are helping shape future directions.
Lillie Killick was 14 years old when diagnosed with leukaemia in 2010. Now 27, she tells us how some of the support she received after treatment helped to inspire her career choices
Supportive care is an area of children’s cancer care that has progressed significantly in recent decades. Dr Bob Phillips and Dr Jess Morgan, members of CCLG’s Supportive Care working group, explain just some of the ways it has improved to help patients and their families cope with their disease and the treatment of it.
It’s not just the type of treatments that doctors look to improve, but the way they can be delivered so they are safer and more effective, too. We hear from two leading experts on already established advancements in eye cancer treatment, and a developing example of progress in brain tumour therapy.
